1. 1813 Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer. (September 2015) Authors: Kotoula, V.; Zagouri, F.; Alexopoulou, Z.; Gogas, H.; Lakis, S.; Pentheroudakis, G.; Bobos, M.; Papadopoulou, K.; Tsolaki, E.; Skondra, M.; Karavasilis, V.; Koutras, A.; Chrisafi, S.; Christodoulou, C.; Papakostas, P.; Linardou, H.; Markopoulos, C.; Zografos, G.; Samantas, E.; Fountzilas, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗